Novartis says that with generative approaches its teams can propose new molecular structures informed by protein information and prior chemistry and optimize multiple properties in parallel.
Novartis says that with generative approaches its teams can propose new molecular structures informed by protein information and prior chemistry and optimize multiple properties in parallel.